Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 468 articles:
HTML format
Text format



Single Articles


    May 2019
  1. NYSTROM T, Sartipy U, Contardi A, Lind M, et al
    Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
    Circulation. 2019;139:2380-2382.
    PubMed     Text format    


  2. BONELLO L, Laine M, Lemesle G
    Letter by Bonello et al Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".
    Circulation. 2019;139:e959-e960.
    PubMed     Text format    


  3. KOFOED KF, Kelbaek H, Engstrom T, Kober LV, et al
    Response by Kofoed et al to Letter Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".
    Circulation. 2019;139:e961-e962.
    PubMed     Text format    


  4. THOMAS RJ, Beatty AL, Beckie TM, Brewer LC, et al
    Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.
    Circulation. 2019 May 13:CIR0000000000000663. doi: 10.1161/CIR.0000000000000663.
    PubMed     Text format     Abstract available


  5. CAPPOLA AR, Desai AS, Medici M, Cooper LS, et al
    Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.
    Circulation. 2019 May 13. doi: 10.1161/CIRCULATIONAHA.118.036859.
    PubMed     Text format     Abstract available


  6. AGIRBASLI M, Aksoy A
    Letter by Agirbasli and Aksoy Regarding Article, "Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population".
    Circulation. 2019;139:e911-e912.
    PubMed     Text format    


  7. DOOSTI-IRANI A, Mansournia MA, Collins G
    Letter by Doosti-Irani et al Regarding Article, "Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population".
    Circulation. 2019;139:e909-e910.
    PubMed     Text format    


    April 2019
  8. RAVNSKOV U, Okuyama H, Sultan S
    Letter by Ravnskov et al Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longit
    Circulation. 2019;139:2188-2189.
    PubMed     Text format    


  9. ABDULLAH SM, Defina LF, Leonard D, Khera A, et al
    Response by Abdullah et al to Letters Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper
    Circulation. 2019;139:2192-2193.
    PubMed     Text format    


  10. KE C, Shen Y
    Letter by Ke and Shen Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudi
    Circulation. 2019;139:2190-2191.
    PubMed     Text format    


  11. BANGALORE S
    Response by Bangalore to Letter Regarding Article, "Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials".
    Circulation. 2019;139:2083-2084.
    PubMed     Text format    


  12. ROMAGUERA R, Gomez-Lara J, Gomez-Hospital JA
    Letter by Romaguera et al Regarding Article, "Newer Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials".
    Circulation. 2019;139:2081-2082.
    PubMed     Text format    


  13. SANO M, Goto S
    Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects.
    Circulation. 2019;139:1985-1987.
    PubMed     Text format    


  14. KEY TJ, Appleby PN, Bradbury KE, Sweeting M, et al
    Consumption of Meat, Fish, Dairy Products, Eggs and Risk of Ischemic Heart Disease: A Prospective Study of 7198 Incident Cases Among 409,885 Participants in the Pan-European EPIC Cohort.
    Circulation. 2019 Apr 22. doi: 10.1161/CIRCULATIONAHA.118.038813.
    PubMed     Text format     Abstract available


  15. PUSKAS JD, Gaudino M, Taggart DP
    Experience Is Crucial in Off-Pump Coronary Artery Bypass Grafting.
    Circulation. 2019;139:1872-1875.
    PubMed     Text format    


  16. PAHIGIANNIS K, Thompson-Paul AM, Barfield W, Ochiai E, et al
    Progress Toward Improved Cardiovascular Health in the United States.
    Circulation. 2019;139:1957-1973.
    PubMed     Text format     Abstract available


  17. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    PubMed     Text format     Abstract available


  18. MARKLUND M, Wu JHY, Imamura F, Del Gobbo LC, et al
    Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.
    Circulation. 2019 Apr 11. doi: 10.1161/CIRCULATIONAHA.118.038908.
    PubMed     Text format     Abstract available


  19. GUASCH-FERRE M, Satija A, Blondin SA, Janiszewski M, et al
    Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors.
    Circulation. 2019;139:1828-1845.
    PubMed     Text format     Abstract available


  20. GILCHRIST SC, Barac A, Ades PA, Alfano CM, et al
    Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Apr 8:CIR0000000000000679. doi: 10.1161/CIR.0000000000000679.
    PubMed     Text format     Abstract available


  21. SATTAR N, Rawshani A, Franzen S, Rawshani A, et al
    Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks Findings From the Swedish National Diabetes Registry.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.037885.
    PubMed     Text format    


  22. HUANG S, Li X, Zheng H, Si X, et al
    Loss of Super-Enhancer-Regulated CircRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice.
    Circulation. 2019 Apr 5. doi: 10.1161/CIRCULATIONAHA.118.038361.
    PubMed     Text format     Abstract available


  23. ERLINGE D
    Cangrelor for ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2019;139:1671-1673.
    PubMed     Text format    


  24. MILLS NL, Omland T
    Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction.
    Circulation. 2019;139:1655-1657.
    PubMed     Text format    


  25. LOW WANG CC, Everett BM, Burman KD, Wilson PWF, et al
    Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?
    Circulation. 2019;139:1741-1743.
    PubMed     Text format    



  26. Correction to: High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD).
    Circulation. 2019;139:e836.
    PubMed     Text format    


  27. BRILAKIS ES, Mashayekhi K, Burke MN
    How DECISION-CTO Can Help Guide the Decision to Perform Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;139:1684-1687.
    PubMed     Text format    


  28. SLIWA K, Ntusi N
    Battling Cardiovascular Diseases in a Perfect Storm.
    Circulation. 2019;139:1658-1660.
    PubMed     Text format    


  29. KOMATSU Y, Hocini M, Nogami A, Maury P, et al
    Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study.
    Circulation. 2019 Apr 1. doi: 10.1161/CIRCULATIONAHA.118.037997.
    PubMed     Text format     Abstract available


    March 2019
  30. TAMIS-HOLLAND JE, Jneid H, Reynolds HR, Agewall S, et al
    Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Mar 27:CIR0000000000000670. doi: 10.1161/CIR.0000000000000670.
    PubMed     Text format     Abstract available


  31. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
    Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
    PubMed     Text format     Abstract available


  32. PLAYAN-ESCRIBANO J, Martinez-Losas P, Cobos-Gil MA
    Electrocardiographic Changes After Angioplasty of the Left Anterior Descending Coronary Artery.
    Circulation. 2019;139:1550-1553.
    PubMed     Text format    


  33. FURTADO RHM, Bonaca MP, Raz I, Zelniker TA, et al
    Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039996.
    PubMed     Text format     Abstract available


  34. BONSU J, Charles L, Guha A, Awan F, et al
    Representation of Patients with Cardiovascular Disease in Pivotal Cancer Clinical Trials.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.118.039180.
    PubMed     Text format     Abstract available


  35. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17:CIR0000000000000678. doi: 10.1161/CIR.0000000000000678.
    PubMed     Text format    


  36. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    Circulation. 2019 Mar 17:CIR0000000000000677. doi: 10.1161/CIR.0000000000000677.
    PubMed     Text format    


  37. BITTNER VA
    The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040625.
    PubMed     Text format     Abstract available


  38. PICKERING JW
    The Need to Improve Derivation and Description of Algorithms to Rule-Out Patients With Possible Myocardial Infarction.
    Circulation. 2019;139:1351-1353.
    PubMed     Text format    


  39. LONG M, Ye Z, Li L
    Letter by Long et al Regarding Article, "Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease".
    Circulation. 2019;139:1467-1468.
    PubMed     Text format    


  40. BHATNAGAR A, Maziak W, Eissenberg T, Ward KD, et al
    Water Pipe (Hookah) Smoking and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Mar 8:CIR0000000000000671. doi: 10.1161/CIR.0000000000000671.
    PubMed     Text format     Abstract available


  41. KUWABARA M
    Letter by Kuwabara Regarding Article, "Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study".
    Circulation. 2019;139:1348-1349.
    PubMed     Text format    


  42. DORING Y, van der Vorst EPC, Duchene J, Jansen Y, et al
    CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease.
    Circulation. 2019;139:1338-1340.
    PubMed     Text format    


    February 2019
  43. BURROUGHS-PENA MS, Mbassa RS, Slopen NB, Williams DR, et al
    Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women: Data by Race/Ethnicity.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.033915.
    PubMed     Text format     Abstract available


  44. SAHA P, Potiny P, Rigdon J, Morello M, et al
    Substantial Cardiovascular Morbidity in Adults with Lower-Complexity Congenital Heart Disease.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.037064.
    PubMed     Text format     Abstract available


  45. LEE SW, Lee PH, Ahn JM, Park DW, et al
    Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.031313.
    PubMed     Text format     Abstract available


  46. MEHTA A, Mandawat A
    Letter by Mehta and Mandawat Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".
    Circulation. 2019;139:1243-1244.
    PubMed     Text format    



  47. Correction to: Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:e55.
    PubMed     Text format    


  48. NAFEE T, Gibson CM, Yee MK, Kerneis M, et al
    Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
    Circulation. 2019;139:1234-1236.
    PubMed     Text format    


  49. SIMES J, Kirby A, Tonkin A
    Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".
    Circulation. 2019;139:1245-1246.
    PubMed     Text format    


  50. DIVANJI P, Deo R, Harris I
    Coronary Arteries and the Cell Count.
    Circulation. 2019;139:1228-1233.
    PubMed     Text format    


  51. RAWSHANI A, Rawshani A, Sattar N, Franzen S, et al
    Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes.
    Circulation. 2019 Feb 25. doi: 10.1161/CIRCULATIONAHA.118.037454.
    PubMed     Text format     Abstract available


  52. DE FERRANTI SD, Steinberger J, Ameduri R, Baker A, et al
    Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Feb 25:CIR0000000000000618. doi: 10.1161/CIR.0000000000000618.
    PubMed     Text format     Abstract available


  53. ZELNIKER TA, Wiviott SD, Raz I, Im K, et al
    Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of
    Circulation. 2019 Feb 21. doi: 10.1161/CIRCULATIONAHA.118.038868.
    PubMed     Text format     Abstract available


  54. VACCARINO V
    Myocardial Infarction in Young Women.
    Circulation. 2019;139:1057-1059.
    PubMed     Text format    


  55. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    PubMed     Text format     Abstract available


  56. BARISH R, Lynce F, Unger K, Barac A, et al
    Management of Cardiovascular Disease in Women With Breast Cancer.
    Circulation. 2019;139:1110-1120.
    PubMed     Text format     Abstract available


  57. BUI QM, Daniels LB
    A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women.
    Circulation. 2019;139:1094-1101.
    PubMed     Text format     Abstract available


  58. KALINOWSKI J, Taylor JY, Spruill TM
    Why Are Young Black Women at High Risk for Cardiovascular Disease?
    Circulation. 2019;139:1003-1004.
    PubMed     Text format    


  59. OUYANG D, Harrington RA, Rodriguez F
    Association Between Female Corresponding Authors and Female Co-Authors in Top Contemporary Cardiovascular Medicine Journals.
    Circulation. 2019;139:1127-1129.
    PubMed     Text format    


  60. HAN JK, Yano EM, Watson KE, Ebrahimi R, et al
    Cardiovascular Care in Women Veterans.
    Circulation. 2019;139:1102-1109.
    PubMed     Text format     Abstract available


  61. GRANDI SM, Filion KB, Yoon S, Ayele HT, et al
    Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications.
    Circulation. 2019;139:1069-1079.
    PubMed     Text format     Abstract available


  62. BELLETTIERE J, LaMonte MJ, Evenson KR, Rillamas-Sun E, et al
    Sedentary behavior and cardiovascular disease in older women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study.
    Circulation. 2019;139:1036-1046.
    PubMed     Text format     Abstract available


  63. NOTA NM, Wiepjes CM, de Blok CJM, Gooren LJG, et al
    The Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy: Results from a Large Cohort Study.
    Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.038584.
    PubMed     Text format     Abstract available


  64. BENSCHOP L, Schalekamp-Timmermans S, Broere-Brown ZA, Roeters van Lennep JE, et al
    Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.036632.
    PubMed     Text format     Abstract available


  65. RABINOVICH-NIKITIN I, Lieberman B, Martino TA, Kirshenbaum LA, et al
    Circadian-Regulated Cell Death in Cardiovascular Diseases.
    Circulation. 2019;139:965-980.
    PubMed     Text format     Abstract available


  66. MORROW DA, Wiviott SD
    Classification of Deaths in Cardiovascular Outcomes Trials.
    Circulation. 2019;139:874-876.
    PubMed     Text format    


  67. SPATZ ES, Herrin J
    Cardiovascular Outcomes in the Wake of Financial Uncertainty.
    Circulation. 2019;139:860-862.
    PubMed     Text format    


  68. MORDI IR, Pearson ER, Palmer CNA, Doney ASF, et al
    Differential Association of Genetic Risk of Coronary Artery Disease With Development of Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Circulation. 2019;139:986-988.
    PubMed     Text format    


  69. DIEGELER A, Borgermann J, Kappert U, Hilker M, et al
    Five-Year Outcome after Off-Pump or On-Pump Coronary Artery Bypass Grafting in Elderly Patients.
    Circulation. 2019 Feb 8. doi: 10.1161/CIRCULATIONAHA.118.035857.
    PubMed     Text format     Abstract available


  70. LI DJ, Chen XP, Zhang XB
    Letter by Li et al Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:839-840.
    PubMed     Text format    


  71. BRINTON TJ, Ali ZA, Hill JM, Meredith IT, et al
    Feasibility of Shockwave Coronary Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses.
    Circulation. 2019;139:834-836.
    PubMed     Text format    


  72. SU Q, Li Q
    Letter by Su and Li Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:837-838.
    PubMed     Text format    


  73. PETRIE JR, Sattar N
    Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.
    Circulation. 2019;139:744-747.
    PubMed     Text format    


  74. UDDIN SMI, Dardari Z, Blaha MJ
    Response by Uddin et al to Letters Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:841-842.
    PubMed     Text format    


    January 2019
  75. LIM CC, Hayes RB, Ahn J, Shao Y, et al
    Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk.
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035742.
    PubMed     Text format     Abstract available


  76. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
    Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients with Coronary Heart Disease.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.038036.
    PubMed     Text format     Abstract available


  77. WANG Y, Dembowsky K, Chevalier E, Stuve P, et al
    C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.036053.
    PubMed     Text format     Abstract available


  78. MCMILLAN A, Hazen SL
    Gut Microbiota Involvement in Ventricular Remodeling Post-Myocardial Infarction.
    Circulation. 2019;139:660-662.
    PubMed     Text format    


  79. MCCLELLAN M, Brown N, Califf RM, Warner JJ, et al
    Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2019 Jan 24:CIR0000000000000652. doi: 10.1161/CIR.0000000000000652.
    PubMed     Text format     Abstract available


  80. PARE G, Caku A, McQueen M, Anand SS, et al
    Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.034311.
    PubMed     Text format     Abstract available


  81. SANDOVAL Y, Jaffe AS, Apple FS
    Letter by Sandoval et al Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction".
    Circulation. 2019;139:562-563.
    PubMed     Text format    


  82. MCCORD J, Newby LK, deFilippi CR
    Response by McCord et al to Letter Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Inf
    Circulation. 2019;139:564-565.
    PubMed     Text format    


  83. HAO Y, Liu J, Liu J, Yang N, et al
    Sex Differences in In-hospital Management and Outcomes of Patients with Acute Coronary Syndrome: Findings from the Improving Care for Cardiovascular Disease in China (CCC) Project.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.037655.
    PubMed     Text format     Abstract available


  84. SHARMA M, Hart RG, Connolly SJ, Bosch J, et al
    Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.035864.
    PubMed     Text format     Abstract available


  85. ATIENZA F, Marquez MF, Sanchez-Quintana D
    Letter by Atienza et al Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
    Circulation. 2019;139:566-567.
    PubMed     Text format    


  86. THIENE G, Saffitz JE
    Response by Thiene and Saffitz to Letter Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
    Circulation. 2019;139:568-569.
    PubMed     Text format    



  87. Correction to: Waiting for Godot: Engaging in Discussions About Depression Care in Patients With Acute Myocardial Infarction While Waiting for a Definitive Trial That Never Appears.
    Circulation. 2019;139:e7.
    PubMed     Text format    



  88. Correction to: Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2019;139:e9.
    PubMed     Text format    


  89. FIGTREE GA, Radholm K, Neal B
    Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:418-419.
    PubMed     Text format    


  90. KOH KK
    Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:416-417.
    PubMed     Text format    


  91. PATEL MR
    Percutaneous Support Devices for Percutaneous Coronary Intervention.
    Circulation. 2019;139:347-350.
    PubMed     Text format    


  92. FRANCHI F, Rollini F, Rivas A, Wali M, et al
    Platelet Inhibition with Cangrelor and Crushed Ticagrelor in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study.
    Circulation. 2019 Jan 11. doi: 10.1161/CIRCULATIONAHA.118.038317.
    PubMed     Text format     Abstract available



  93. Correction to: Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2019;139:e2.
    PubMed     Text format    


  94. NASSIF ME, Kosiborod M
    Response by Nassif and Kosiborod to Letter Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".
    Circulation. 2019;139:305-306.
    PubMed     Text format    


  95. POTIER L, Roussel R
    Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".
    Circulation. 2019;139:303-304.
    PubMed     Text format    


  96. ELFASSY T, Swift SL, Glymour MM, Calonico S, et al
    Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015.
    Circulation. 2019 Jan 7. doi: 10.1161/CIRCULATIONAHA.118.035521.
    PubMed     Text format    


  97. VANHAVERBEKE M, Bogaerts K, Sinnaeve PR, Janssens L, et al
    Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:137-139.
    PubMed     Text format    


  98. OEMRAWSINGH RM, Akkerhuis KM, de Mulder M, Umans VA, et al
    High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.
    Circulation. 2019;139:134-136.
    PubMed     Text format    


  99. PRABHAKARAN D, Jaacks LM
    Reflections From India on Scaling Up Risk Factor Control for Cardiovascular Diseases to Reach 1 Billion Adults.
    Circulation. 2019;139:4-6.
    PubMed     Text format    


  100. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    PubMed     Text format     Abstract available


    December 2018
  101. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    PubMed     Text format     Abstract available


  102. FRIEDMAN DJ, Al-Khatib SM
    Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2972-2973.
    PubMed     Text format    


  103. BROUWER TF, Burke MC, Knops RE
    Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2970-2971.
    PubMed     Text format    


  104. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    PubMed     Text format     Abstract available


  105. DEFILIPPIS EM, Singh A, Gupta A, Ayuba G, et al
    Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction.
    Circulation. 2018;138:2855-2857.
    PubMed     Text format    


  106. KOFOED KF, Kelbaek H, Hansen PR, Torp-Pedersen C, et al
    Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Circulation. 2018;138:2741-2750.
    PubMed     Text format     Abstract available


  107. JOLLY SS, Mehta SR
    Timing of Intervention in Non-ST Elevation Acute Coronary Syndromes.
    Circulation. 2018;138:2751-2753.
    PubMed     Text format    



  108. Correction to: Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial.
    Circulation. 2018;138:e750.
    PubMed     Text format    


  109. JERNBERG T, Lindahl B, Alfredsson J, Berglund E, et al
    Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
    Circulation. 2018;138:2754-2762.
    PubMed     Text format     Abstract available


  110. PENCINA MJ, Navar AM, Wojdyla D, Sanchez RJ, et al
    Quantifying Importance of Major Risk Factors for Coronary Heart Disease.
    Circulation. 2018 Dec 7. doi: 10.1161/CIRCULATIONAHA.117.031855.
    PubMed     Text format     Abstract available


  111. FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
    Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
    Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
    PubMed     Text format     Abstract available


  112. SCHRAGE B, Ibrahim K, Loehn T, Werner N, et al
    Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.036614.
    PubMed     Text format     Abstract available


  113. TSUTSUMI K, Tsukahara K
    Is The Diagnosis ST-Segment Elevation or Non-ST-Segment Elevation Myocardial Infarction?
    Circulation. 2018;138:2715-2717.
    PubMed     Text format    


  114. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2724-2725.
    PubMed     Text format    


  115. KIMURA T, Iimuro S, Taguchi I, Iwata H, et al
    Response by Kimura et al to Letters Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2728-2729.
    PubMed     Text format    


  116. GONG L, Cao Y, Yang G
    Letter by Gong et al Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2726-2727.
    PubMed     Text format    


  117. DUFF JP, Topjian A, Berg MD, Chan M, et al
    2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2018;138:e731-e739.
    PubMed     Text format     Abstract available


  118. SOAR J, Donnino MW, Maconochie I, Aickin R, et al
    2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2018;138:e714-e730.
    PubMed     Text format     Abstract available


  119. PANCHAL AR, Berg KM, Kudenchuk PJ, Del Rios M, et al
    2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation an
    Circulation. 2018;138:e740-e749.
    PubMed     Text format     Abstract available


  120. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    PubMed     Text format     Abstract available


  121. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    PubMed     Text format     Abstract available


    November 2018
  122. O'DONOGHUE ML, Fazio S, Giugliano RP, Stroes ESG, et al
    Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial.
    Circulation. 2018 Nov 30. doi: 10.1161/CIRCULATIONAHA.118.037184.
    PubMed     Text format     Abstract available


  123. MENTZ RJ, Thompson VP, Aguilar D, Choi J, et al
    Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
    Circulation. 2018;138:2576-2578.
    PubMed     Text format    


  124. CAO DJ
    Macrophages in Cardiovascular Homeostasis and Disease.
    Circulation. 2018;138:2452-2455.
    PubMed     Text format    


  125. AMEGAH AK
    Tackling the Growing Burden of Cardiovascular Diseases in Sub-Saharan Africa.
    Circulation. 2018;138:2449-2451.
    PubMed     Text format    


  126. SOUSA GR, Pober D, Galderisi A, Lv H, et al
    Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort-Based Study.
    Circulation. 2018 Nov 26. doi: 10.1161/CIRCULATIONAHA.118.036068.
    PubMed     Text format     Abstract available


  127. BUDOFF MJ, Lutz SM, Kinney GL, Young KA, et al
    Coronary Artery Calcium on Noncontrast Thoracic Computerized Tomography Scans and All-Cause Mortality.
    Circulation. 2018;138:2437-2438.
    PubMed     Text format    


  128. ABDULLAH SM, Defina LF, Leonard D, Barlow CE, et al
    Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018;138:2315-2325.
    PubMed     Text format     Abstract available


  129. WADE KH, Chiesa ST, Hughes AD, Chaturvedi N, et al
    Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses.
    Circulation. 2018;138:2187-2201.
    PubMed     Text format     Abstract available



  130. Correction to: Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e652.
    PubMed     Text format    


  131. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e618-e651.
    PubMed     Text format    


  132. KATZ S, Smilowitz NR, Hochman JS
    Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038279.
    PubMed     Text format     Abstract available


  133. KHERA AV, Chaffin M, Zekavat SM, Collins RL, et al
    Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035658.
    PubMed     Text format     Abstract available


  134. KAPUR NK, Alkhouli M, DeMartini T, Faraz H, et al
    Unloading the Left Ventricle Before Reperfusion in Patients with Anterior ST-Segment Elevation Myocardial Infarction: A Pilot Study Using the Impella CP((R)).
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038269.
    PubMed     Text format     Abstract available


  135. ARORA S, Stouffer GAR, Kucharska-Newton A, Qamar A, et al
    Twenty Year Trends and Sex Differences in Young Adults Hospitalized with Acute Myocardial Infarction: The ARIC Community Surveillance Study.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.037137.
    PubMed     Text format     Abstract available


  136. THIELE H, Zeymer U, Thelemann N, Neumann FJ, et al
    Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038201.
    PubMed     Text format     Abstract available


  137. BANGALORE S
    The Elusive Late Benefit of Biodegradable Polymer Drug Eluting Stents.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038378.
    PubMed     Text format     Abstract available


  138. KUFNER S, Joner M, Thannheimer A, Hoppmann P, et al
    Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038065.
    PubMed     Text format     Abstract available


  139. MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
    Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
    PubMed     Text format     Abstract available


  140. LLOYD-JONES DM, Braun LT, Ndumele CE, Smith SC Jr, et al
    Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018 Nov 10:CIR0000000000000638. doi: 10.1161/CIR.0000000000000638.
    PubMed     Text format     Abstract available


  141. VON BORNSTADT D, Wang H, Paulsen MJ, Goldstone AB, et al
    Rapid Self-Assembly of Bioengineered Cardiovascular Bypass Grafts From Scaffold-Stabilized, Tubular Bilevel Cell Sheets.
    Circulation. 2018;138:2130-2144.
    PubMed     Text format     Abstract available


  142. ROCHA RV, Tam DY, Karkhanis R, Nedadur R, et al
    Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Circulation. 2018;138:2081-2090.
    PubMed     Text format     Abstract available


  143. DOMANSKI MJ, Farkouh ME
    Optimal Treatment of Patients With Left Ventricular Dysfunction and Severe Coronary Artery Disease.
    Circulation. 2018;138:2079-2080.
    PubMed     Text format    


  144. RUEL M, Gardner TJ
    Introduction to the 2018 Cardiovascular Surgery-Themed Issue.
    Circulation. 2018;138:2075.
    PubMed     Text format    


    October 2018
  145. VIGEN R, Kutscher P, Fernandez F, Yu A, et al
    Evaluation of a Novel Rule-Out Myocardial Infarction Protocol Incorporating High-Sensitivity Troponin T in a US Hospital.
    Circulation. 2018;138:2061-2063.
    PubMed     Text format    


  146. VAN LEEUWEN MAH, van der Hoeven NW, Janssens GN, Everaars H, et al
    Evaluation of Microvascular Injury in Revascularized Patients with ST Elevation Myocardial Infarction Treated with Ticagrelor versus Prasugrel: The REDUCE-MVI Trial.
    Circulation. 2018 Oct 30. doi: 10.1161/CIRCULATIONAHA.118.035931.
    PubMed     Text format     Abstract available


  147. MAULER M, Herr N, Schoenichen C, Witsch T, et al
    Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
    Circulation. 2018 Oct 25. doi: 10.1161/CIRCULATIONAHA.118.033942.
    PubMed     Text format     Abstract available


  148. INZUCCHI SE, Kosiborod M, Fitchett D, Wanner C, et al
    Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.
    Circulation. 2018;138:1904-1907.
    PubMed     Text format    


  149. DONZELLI A, Schivalocchi A, Giudicatti G
    Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Effica
    Circulation. 2018;138:1912-1913.
    PubMed     Text format    


  150. KOH KK
    Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy Internat
    Circulation. 2018;138:1914-1915.
    PubMed     Text format    


  151. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Text format     Abstract available


  152. NISHI T, Piroth Z, De Bruyne B, Jagic N, et al
    Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
    Circulation. 2018;138:1797-1804.
    PubMed     Text format     Abstract available


  153. NICCOLI G, Montone RA, Sabato V, Crea F, et al
    Role of Allergic Inflammatory Cells in Coronary Artery Disease.
    Circulation. 2018;138:1736-1748.
    PubMed     Text format     Abstract available


  154. CHAPMAN AR, Hesse K, Andrews J, Ken Lee K, et al
    High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome.
    Circulation. 2018;138:1654-1665.
    PubMed     Text format     Abstract available


  155. JAMES M, Manns B
    Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease.
    Circulation. 2018;138:1515-1518.
    PubMed     Text format    


  156. VERMA S, Leiter LA, Mazer CD, Bain SC, et al
    Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Circulation. 2018;138:1605-1607.
    PubMed     Text format    


  157. CLAGGETT B, Lachin JM, Hantel S, Fitchett D, et al
    Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
    Circulation. 2018;138:1599-1601.
    PubMed     Text format    


  158. BONELLO L, Angiolillo DJ, Aradi D, Sibbing D, et al
    P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.
    Circulation. 2018;138:1582-1596.
    PubMed     Text format     Abstract available


  159. DAI Y, Song J, Li W, Yang T, et al
    RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
    Circulation. 2018 Oct 5. doi: 10.1161/CIRCULATIONAHA.118.033700.
    PubMed     Text format     Abstract available


  160. LINDOW T, Warren S, Pahlm O
    Two Patients With Inferior ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2018;138:1481-1484.
    PubMed     Text format    


  161. KASKI JC, Crea F, Gersh BJ, Camici PG, et al
    Reappraisal of Ischemic Heart Disease.
    Circulation. 2018;138:1463-1480.
    PubMed     Text format     Abstract available


  162. NEELAND IJ, Poirier P, Despres JP
    Response by Neeland et al to Letter Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1496-1497.
    PubMed     Text format    


  163. KAHN HS
    Letter by Kahn Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1494-1495.
    PubMed     Text format    


    September 2018
  164. FAN Q, Tao R, Zhang H, Xie H, et al
    Dectin-1 Contributes to Myocardial Ischemia-Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.
    Circulation. 2018 Sep 27. doi: 10.1161/CIRCULATIONAHA.118.036044.
    PubMed     Text format     Abstract available


  165. ROLLINI F, Franchi F
    Standard- and Low-Dose Ticagrelor After Percutaneous Coronary Intervention.
    Circulation. 2018;138:1301-1303.
    PubMed     Text format    


  166. GIMPEL D, Ray M
    Time to Get a @Handle on Twitter and Cardiovascular Medicine.
    Circulation. 2018;138:1285-1286.
    PubMed     Text format    


  167. KUEHN BM
    Boosting Women's Participation in Cardiovascular Trials.
    Circulation. 2018;138:1366-1367.
    PubMed     Text format    


  168. LEMESLE G
    Aspirin on Top of Anticoagulation in Patients with Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037440.
    PubMed     Text format    


  169. MATSUMURA-NAKANO Y, Shizuta S, Komasa A, Morimoto T, et al
    An Open-Label Randomized Trial Comparing Oral Anticoagulation with and without Single Antiplatelet Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease Beyond One Year after Coronary Stent Implantation: The OAC-ALONE Study.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.036768.
    PubMed     Text format     Abstract available


  170. FEARON WF, Achenbach S, Engstrom T, Assali A, et al
    Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037350.
    PubMed     Text format     Abstract available


  171. RODEN DM
    Growing Pains in Cardiovascular Genetics.
    Circulation. 2018;138:1206-1209.
    PubMed     Text format    


  172. FANAROFF AC, Zakroysky P, Wojdyla D, Kaltenbach LA, et al
    Relationship Between Operator Volume and Long-Term Outcomes after Percutaneous Coronary Intervention: A Report from the NCDR CathPCI Registry.
    Circulation. 2018 Sep 12. doi: 10.1161/CIRCULATIONAHA.117.033325.
    PubMed     Text format     Abstract available


  173. CHAPMAN AR, Mills NL
    Response To Letter Regarding Article "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1178.
    PubMed     Text format    


  174. MADIAS JE
    Letter by Madias Regarding Article, "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1176-1177.
    PubMed     Text format    


  175. WHITE WB
    Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes.
    Circulation. 2018;138:1127-1129.
    PubMed     Text format    


  176. HSUE PY, Waters DD
    Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor.
    Circulation. 2018;138:1113-1115.
    PubMed     Text format    


  177. WENGER NK, Lorell BH, Bairey Merz CN
    Recent Legislation, Public Policy Changes, and Women's Cardiovascular Health.
    Circulation. 2018;138:1082-1084.
    PubMed     Text format    


  178. YASUDA S, Miyamoto Y, Ogawa H
    Current Status of Cardiovascular Medicine in the Aging Society of Japan.
    Circulation. 2018;138:965-967.
    PubMed     Text format    


    August 2018
  179. SHARKEY SW, Maron BJ, Kloner RA
    The Case for Takotsubo Cardiomyopathy (Syndrome) as a Variant of Acute Myocardial Infarction.
    Circulation. 2018;138:855-857.
    PubMed     Text format    


  180. BODEN WE, Bhatt DL
    Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?
    Circulation. 2018;138:858-860.
    PubMed     Text format    


  181. YI-TONG W
    Letter by Wang Yi-tong Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:852.
    PubMed     Text format    


  182. ZAUNER CA, Holshouser JW, Littmann L
    Response to Letter Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:853-854.
    PubMed     Text format    


  183. TAMPAKIS A, Tampaki EC, Gurke L
    Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:848-849.
    PubMed     Text format    


  184. WANNER C, von Eynatten M, Zinman B
    Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:850-851.
    PubMed     Text format    


  185. KOH KK
    Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:846-847.
    PubMed     Text format    


  186. KYRLE PA, Eichinger S
    D-Dimer for Long-Term Risk Prediction in Patients After Acute Coronary Syndrome.
    Circulation. 2018;138:724-726.
    PubMed     Text format    


  187. HANDY CE, Quispe R, Pinto X, Blaha MJ, et al
    Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment.
    Circulation. 2018;138:727-734.
    PubMed     Text format     Abstract available


  188. MATTHEWS DR, Perkovic V, Mahaffey KW
    Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist".
    Circulation. 2018;138:660-661.
    PubMed     Text format    


  189. HNID K
    Letter by Hnid Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:653-654.
    PubMed     Text format    


  190. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:649-650.
    PubMed     Text format    


  191. KOH KK
    Letter by Koh Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:651-652.
    PubMed     Text format    


  192. DINU M, Pagliai G, Sofi F
    Response by Dinu et al to Letters Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:655.
    PubMed     Text format    


  193. LOWENSTEIN CJ, Weisfeldt ML, Mitchell JH
    Sarnoff Cardiovascular Research Foundation.
    Circulation. 2018;138:554-556.
    PubMed     Text format    


    July 2018
  194. VACCARINO V, Bremner JD, Raggi P
    Response by Vaccarino et al to Letter Regarding Article, "Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms".
    Circulation. 2018;138:548-549.
    PubMed     Text format    



  195. Correction to: European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners R
    Circulation. 2018;138:e80.
    PubMed     Text format    


  196. JIANG X, Tian H, Qiao S
    Letter by Jiang et al Regarding Article, "Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction".
    Circulation. 2018;138:543.
    PubMed     Text format    


  197. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
    Response by Kaier et al to Letter Regarding Article, "Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction".
    Circulation. 2018;138:544-545.
    PubMed     Text format    


  198. SINGH AD, Mian A
    Letter by Singh and Mian Regarding Article, "Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms".
    Circulation. 2018;138:546-547.
    PubMed     Text format    


  199. OMLAND T
    Can Circulating B-Type Natriuretic Peptide Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease?
    Circulation. 2018;138:479-482.
    PubMed     Text format    



  200. Correction to: ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018;138:e77.
    PubMed     Text format    



  201. Correction to: Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018;138:e76.
    PubMed     Text format    


  202. ANGIOLILLO DJ, Goodman SG, Bhatt DL, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.
    Circulation. 2018;138:527-536.
    PubMed     Text format     Abstract available


  203. SHEN C, Ge J
    Epidemic of Cardiovascular Disease in China.
    Circulation. 2018;138:342-344.
    PubMed     Text format    


  204. FUERNAU G, Beck J, Desch S, Eitel I, et al
    Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial.
    Circulation. 2018 Jul 19. pii: CIRCULATIONAHA.117.032722.
    PubMed     Text format     Abstract available


  205. MCCORD J, Newby LK, deFilippi CR
    Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.
    Circulation. 2018;138:316-318.
    PubMed     Text format    


  206. GOLDBERG IJ, Reue K, Abumrad NA, Bickel PE, et al
    Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.
    Circulation. 2018;138:305-315.
    PubMed     Text format     Abstract available


  207. SHEN YM, Nagalla S
    Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
    Circulation. 2018;138:229-231.
    PubMed     Text format    


  208. BONACA MP, Sabatine MS
    Response by Bonaca and Sabatine to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Resea
    Circulation. 2018;138:222-223.
    PubMed     Text format    


  209. ALKHALIL M
    Letter by Alkhalil Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibitio
    Circulation. 2018;138:220-221.
    PubMed     Text format    


  210. CALABRO P, Gragnano F, Cesaro A
    Letter by Calabro et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhi
    Circulation. 2018;138:218-219.
    PubMed     Text format    


  211. IBRAHIM K, Shah R, McEvoy JW
    Response by Ibrahim et al to Letter Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggreg
    Circulation. 2018;138:216-217.
    PubMed     Text format    


  212. KIKKERT WJ, Delewi R, Claessen BEPM
    Letter by Kikkert et al Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With T
    Circulation. 2018;138:214-215.
    PubMed     Text format    


  213. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    PubMed     Text format     Abstract available


  214. KOENIG W
    Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?
    Circulation. 2018;138:150-153.
    PubMed     Text format    


  215. BASCOM KE, Seder DB
    Response by Bascom and Seder to Letter Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:120-121.
    PubMed     Text format    


  216. VOICU S, Megarbane B, Sideris G
    Letter by Voicu et al Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:118-119.
    PubMed     Text format    


  217. ZARZOUR A, Kim HW, Weintraub NL
    Understanding Obesity-Related Cardiovascular Disease: It's All About Balance.
    Circulation. 2018;138:64-66.
    PubMed     Text format    


  218. NASSIF ME, Kosiborod M
    Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.
    Circulation. 2018;138:4-6.
    PubMed     Text format    


  219. SHIRAKAWA K, Endo J, Kataoka M, Katsumata Y, et al
    IL-10-STAT3-Galectin-3 Axis is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.118.035047.
    PubMed     Text format     Abstract available


  220. SHAH ASV, Stelzle D, Lee KK, Beck EJ, et al
    Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.117.033369.
    PubMed     Text format     Abstract available


    June 2018
  221. LABARTHE DR, Lloyd-Jones DM
    50x50x50: Cardiovascular Health and the Cardiovascular Disease Endgame.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.035985.
    PubMed     Text format     Abstract available


  222. BANGALORE S, Toklu B, Patel N, Feit F, et al
    Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Circulation. 2018 Jun 26. pii: CIRCULATIONAHA.118.034456.
    PubMed     Text format     Abstract available


  223. NEUEN BL, Ohkuma T, Neal B, Matthews DR, et al
    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program.
    Circulation. 2018 Jun 25. pii: CIRCULATIONAHA.118.035901.
    PubMed     Text format     Abstract available


  224. RICCIOTTI E, Castro C, Tang SY, Briggs WTE, et al
    Cyclooxygenase-2, Asymmetric Dimethylarginine and the Cardiovascular Hazard from NSAIDs.
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.033540.
    PubMed     Text format     Abstract available


  225. ORME RC, Parker WAE, Thomas MR, Judge HM, et al
    Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.034790.
    PubMed     Text format     Abstract available


  226. THIENE G, Saffitz JE
    Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now.
    Circulation. 2018;137:2683-2685.
    PubMed     Text format    


  227. ZHANG M, Solomon DH, Desai RJ, Kang EH, et al
    Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study.
    Circulation. 2018 Jun 13. pii: CIRCULATIONAHA.118.033992.
    PubMed     Text format     Abstract available


  228. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed     Text format    


  229. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed     Text format    


  230. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed     Text format    


  231. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed     Text format    


  232. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed     Text format    


  233. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    PubMed     Text format     Abstract available


  234. ROBERTS R
    Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease.
    Circulation. 2018;137:2554-2556.
    PubMed     Text format    


  235. UDDIN SMI, Mirbolouk M, Dardari Z, Feldman DI, et al
    Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2018 Jun 11. pii: CIRCULATIONAHA.118.033990.
    PubMed     Text format     Abstract available


  236. BADERTSCHER P, Boeddinghaus J, Twerenbold R, Nestelberger T, et al
    Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction.
    Circulation. 2018;137:2536-2538.
    PubMed     Text format    


  237. PFEFFER MA, Rutherford JD
    Therapeutic Attenuation of Cardiac Remodeling After Acute Myocardial Infarction: A Conversation With Marc A. Pfeffer, MD, PhD.
    Circulation. 2018;137:2430-2434.
    PubMed     Text format    


  238. HYMAN MC, Patel PA, Giri J
    Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
    Circulation. 2018;137:2545-2546.
    PubMed     Text format    


  239. SNIECINSKI RM, Mackensen GB, Kertai MD
    Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
    Circulation. 2018;137:2543-2544.
    PubMed     Text format    


  240. MAGNANI JW, Mujahid MS, Aronow HD, Cene CW, et al
    Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Jun 4. pii: CIR.0000000000000579.
    PubMed     Text format     Abstract available


    May 2018
  241. DEVEREAUX PJ
    Suboptimal Outcome of Myocardial Infarction After Noncardiac Surgery: Physicians Can and Should Do More.
    Circulation. 2018;137:2340-2343.
    PubMed     Text format    



  242. Correction to: Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.
    Circulation. 2018;137:e820.
    PubMed     Text format    


  243. VALLEJO-VAZ AJ, Packard CJ, Ray KK
    Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL
    Circulation. 2018;137:2419-2420.
    PubMed     Text format    


  244. KOH KK
    Letter by Koh Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From th
    Circulation. 2018;137:2417-2418.
    PubMed     Text format    


  245. LOWE AL, Collet TH, Rodondi N
    Letter by Lowe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses
    Circulation. 2018;137:2415-2416.
    PubMed     Text format    


  246. RIJNBERG FM, Hazekamp MG, Wentzel JJ, de Koning PJH, et al
    Energetics of Blood Flow in Cardiovascular Disease: Concept and Clinical Implications of Adverse Energetics in Patients With a Fontan Circulation.
    Circulation. 2018;137:2393-2407.
    PubMed     Text format     Abstract available


  247. VOLGMAN AS, Palaniappan LS, Aggarwal NT, Gupta M, et al
    Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018 May 24. pii: CIR.0000000000000580.
    PubMed     Text format     Abstract available


  248. KIRTANE AJ
    ORBITA2: Bringing Some Oxygen Back to PCI in Stable Ischemic Heart Disease?
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.035331.
    PubMed     Text format     Abstract available


  249. PUYMIRAT E, Simon T, Danchin N
    Response by Puymirat et al to Letter Regarding Article, "Acute Myocardial Infarction Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST Elevation or Non-ST
    Circulation. 2018;137:2307-2308.
    PubMed     Text format    


  250. RODRIGUEZ-GRANILLO GA, Rodriguez AE, Milei J
    Letter by Rodriguez-Granillo et al Regarding Article, "Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-
    Circulation. 2018;137:2305-2306.
    PubMed     Text format    


  251. AL-LAMEE R, Howard JP, Shun-Shin MJ, Thompson D, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA.
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.033801.
    PubMed     Text format     Abstract available


  252. OLDGREN J, Sundstrom J
    Response by Oldgren and Sundstrom to Letter Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2313.
    PubMed     Text format    


  253. YI-TONG W
    Letter by Yi-tong Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2312.
    PubMed     Text format    


  254. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed     Text format    


  255. KENGNE AP, Ntsekhe M
    Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.
    Circulation. 2018;137:2215-2217.
    PubMed     Text format    


  256. LINGVAY I, Leiter LA
    Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical Guide.
    Circulation. 2018;137:2200-2202.
    PubMed     Text format    


  257. RIMM EB, Appel LJ, Chiuve SE, Djousse L, et al
    Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2018 May 17. pii: CIR.0000000000000574.
    PubMed     Text format     Abstract available


  258. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
    Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2186-2187.
    PubMed     Text format    


  259. ROMEO JLR, Bogers AJJC, Mokhles MM
    Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2184-2185.
    PubMed     Text format    


  260. VERMA S, Bhatt DL, Bain SC, Buse JB, et al
    Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
    Circulation. 2018;137:2179-2183.
    PubMed     Text format    


  261. SCHULTZ WM, Kelli HM, Lisko JC, Varghese T, et al
    Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.
    Circulation. 2018;137:2166-2178.
    PubMed     Text format     Abstract available


  262. BROWN HL, Warner JJ, Gianos E, Gulati M, et al
    Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gyneco
    Circulation. 2018 May 10. pii: CIR.0000000000000582.
    PubMed     Text format    


  263. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    PubMed     Text format    


  264. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    PubMed     Text format    


  265. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    PubMed     Text format    


  266. BARTER PJ
    High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death.
    Circulation. 2018;137:2013-2015.
    PubMed     Text format    


  267. TAGUCHI I, Iimuro S, Iwata H, Takashima H, et al
    High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Circulation. 2018;137:1997-2009.
    PubMed     Text format     Abstract available


  268. MAYNE SL, Widome R, Carroll AJ, Schreiner PJ, et al
    Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study.
    Circulation. 2018 May 7. pii: CIRCULATIONAHA.117.032302.
    PubMed     Text format     Abstract available


  269. KARAM N, Pechmajou L, Dumas F, Bougouin W, et al
    Comprehensive Assessment of Coronary Artery Disease in Sports-Related Sudden Cardiac Arrest.
    Circulation. 2018 May 2. pii: CIRCULATIONAHA.118.034664.
    PubMed     Text format     Abstract available


  270. GOLDWASSER D, Elizari M, Bayes de Luna A
    Response by Goldwasser et al to Letter Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1977-1978.
    PubMed     Text format    


  271. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1976.
    PubMed     Text format    


  272. BULLUCK H, Dharmakumar R, Arai AE, Berry C, et al
    Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions.
    Circulation. 2018;137:1949-1964.
    PubMed     Text format     Abstract available


  273. THOMPSON PD
    Fitness, Exercise, and Coronary Calcification.
    Circulation. 2018;137:1896-1898.
    PubMed     Text format    


    April 2018
  274. WEI WQ, Li X, Feng Q, Kubo M, et al
    LPA Variants are Associated with Residual Cardiovascular Risk in Patients Receiving Statins.
    Circulation. 2018 Apr 27. pii: CIRCULATIONAHA.117.031356.
    PubMed     Text format     Abstract available


  275. KLEINMAN ME, Perkins GD, Bhanji F, Billi JE, et al
    ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018 Apr 26. pii: CIR.0000000000000561.
    PubMed     Text format     Abstract available


  276. VAN DER LINDEN N, Wildi K, Twerenbold R, Pickering JW, et al
    Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2018 Apr 24. pii: CIRCULATIONAHA.117.032003.
    PubMed     Text format     Abstract available


  277. RUBINI GIMENEZ M, Badertscher P, Twerenbold R, Boeddinghaus J, et al
    Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction.
    Circulation. 2018;137:1867-1869.
    PubMed     Text format    


  278. HASEEB S, Alexander B, Baranchuk A
    Response by Haseeb et al to Letter Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1880-1881.
    PubMed     Text format    


  279. THORNTON SN
    Letter by Thornton Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1879.
    PubMed     Text format    


  280. HUANG ZP, Wang DZ
    miR-22 in Smooth Muscle Cells: A Potential Therapy for Cardiovascular Disease.
    Circulation. 2018;137:1842-1845.
    PubMed     Text format    


  281. FERNANDEZ-JIMENEZ R, Martin-Garcia A, Barreiro-Perez M, Sanchez-Gonzalez J, et al
    Response by Fernandez-Jimenez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1754-1755.
    PubMed     Text format    


  282. STIERMAIER T, Bogaert J, Eitel I
    Letter by Stiermaier et al Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1752-1753.
    PubMed     Text format    


  283. SACHA J, Feusette P
    Letter by Sacha and Feusette Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1750-1751.
    PubMed     Text format    


  284. BULLUCK H, Hausenloy DJ
    Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1748-1749.
    PubMed     Text format    


  285. VERHEUGT FWA
    Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Circulation. 2018;137:1655-1657.
    PubMed     Text format    


  286. REDFORS B, Chen S, Crowley A, Ben-Yehuda O, et al
    B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial.
    Circulation. 2018 Apr 17. pii: CIRCULATIONAHA.118.033631.
    PubMed     Text format     Abstract available


  287. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Response by Ahmad et al to Letter Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1761-1762.
    PubMed     Text format    


  288. MEWTON N, Bergerot C, Cornu C
    Letter by Mewton et al Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1759-1760.
    PubMed     Text format    


  289. PACK QR, Priya A, Lagu TC, Pekow PS, et al
    Inpatient Echocardiography Use for Common Cardiovascular Conditions.
    Circulation. 2018;137:1745-1747.
    PubMed     Text format    


  290. BAIBHAV B, Gedela M, Moulton M, Pavlides G, et al
    Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.
    Circulation. 2018;137:1731-1739.
    PubMed     Text format     Abstract available


  291. BAKAEEN FG, Svensson LG
    Why Don't We Kill 2 Birds with 1 Stone? Less Adverse Cardiac Events and Improved Survival With Multiarterial Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1708-1711.
    PubMed     Text format    


  292. GAUDINO M, Fremes SE, Taggart DP
    Continuing Conundrum of Multiple Arterial Conduits for Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1658-1660.
    PubMed     Text format    


  293. PATEL KV, Pandey A, de Lemos JA
    A Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.
    Circulation. 2018 Apr 11. pii: CIRCULATIONAHA.118.035289.
    PubMed     Text format     Abstract available


  294. FIOL-SALA M, Bayes de Luna A
    Response by Fiol-Sala and Bayes de Luna to Letter Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1653.
    PubMed     Text format    


  295. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1652.
    PubMed     Text format    


  296. NALLAMOTHU BK, Hill JA
    Response by Nallamothu and Hill to Letter Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1643-1644.
    PubMed     Text format    


  297. KATRITSIS DG
    Letter by Katritsis Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1641-1642.
    PubMed     Text format    


  298. SHARIFZADEHGAN A, Marijon E, Bougouin W, Karam N, et al
    Sudden Cardiovascular Arrest During Sexual Intercourse.
    Circulation. 2018;137:1638-1640.
    PubMed     Text format    


  299. DUNBAR SB, Khavjou OA, Bakas T, Hunt G, et al
    Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Circulation. 2018 Apr 9. pii: CIR.0000000000000570.
    PubMed     Text format     Abstract available


  300. TIKKANEN E, Gustafsson S, Ingelsson E
    Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
    Circulation. 2018 Apr 9. pii: CIRCULATIONAHA.117.032432.
    PubMed     Text format     Abstract available


  301. SABATINE MS, De Ferrari GM, Giugliano RP, Huber K, et al
    Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER.
    Circulation. 2018 Apr 6. pii: CIRCULATIONAHA.118.034309.
    PubMed     Text format     Abstract available


  302. VALLEJO-VAZ AJ, Fayyad R, Boekholdt SM, Hovingh GK, et al
    Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial.
    Circulation. 2018 Apr 4. pii: CIRCULATIONAHA.117.032318.
    PubMed     Text format     Abstract available


  303. OLDE ENGBERINK RHG, van den Born BH, Peters-Sengers H, Vogt L, et al
    Response by Olde Engberink et al to Letter Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
    Circulation. 2018;137:1538-1539.
    PubMed     Text format    


  304. GRAUDAL N, Mente A
    Letter by Graudal and Mente Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
    Circulation. 2018;137:1536-1537.
    PubMed     Text format    


  305. AUGER N, Potter BJ, Bilodeau-Bertrand M, Paradis G, et al
    Long-Term Risk of Cardiovascular Disease in Women Who Have Had Infants With Heart Defects.
    Circulation. 2018 Apr 2. pii: CIRCULATIONAHA.117.030277.
    PubMed     Text format     Abstract available


    March 2018
  306. PASUPATHY S, Tavella R, Beltrame JF
    Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Inf
    Circulation. 2018;137:1424-1425.
    PubMed     Text format    


  307. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Tria
    Circulation. 2018;137:1422-1423.
    PubMed     Text format    


  308. MANSOUR A, Le Breton H, Auffret V
    Letter by Mansour et al Regarding Article, "Early Use of N-Acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM
    Circulation. 2018;137:1420-1421.
    PubMed     Text format    


  309. KHAN AA, Boyle AJ
    Letter by Khan and Boyle Regarding Article, "Early Use of N-Acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The
    Circulation. 2018;137:1418-1419.
    PubMed     Text format    


  310. NEELAND IJ, Poirier P, Despres JP
    Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.
    Circulation. 2018;137:1391-1406.
    PubMed     Text format     Abstract available


  311. DELGADO V, Hundley WG
    Added Value of Cardiovascular Magnetic Resonance in Primary Mitral Regurgitation.
    Circulation. 2018;137:1361-1363.
    PubMed     Text format    


  312. BRILAKIS ES
    Innovations in Radiation Safety During Cardiovascular Catheterization.
    Circulation. 2018;137:1317-1319.
    PubMed     Text format    


  313. THIELE H, Desch S
    CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock): Implications on Guideline Recommendations.
    Circulation. 2018;137:1314-1316.
    PubMed     Text format    


  314. ZAUNER CA, Holshouser JW, Littmann L
    Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
    Circulation. 2018;137:1287-1289.
    PubMed     Text format    


  315. ANDERSSON C, Lyass A, Lin H, Kober L, et al
    Association of Genetic Variation in Coronary Artery Disease-Related Loci With the Risk of Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Circulation. 2018;137:1290-1292.
    PubMed     Text format    


  316. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    PubMed     Text format    


  317. BETHEL MA, McMurray JJV
    Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist.
    Circulation. 2018;137:1218-1220.
    PubMed     Text format    


  318. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed     Text format    


  319. SCOTT JM, Nilsen TS, Gupta D, Jones LW, et al
    Exercise Therapy and Cardiovascular Toxicity in Cancer.
    Circulation. 2018;137:1176-1191.
    PubMed     Text format     Abstract available


  320. CREA F, Liuzzo G
    Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study).
    Circulation. 2018;137:1100-1102.
    PubMed     Text format    


  321. BOHULA EA, Giugliano RP, Leiter LA, Verma S, et al
    Inflammatory and Cholesterol Risk in the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk).
    Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034032.
    PubMed     Text format     Abstract available


  322. FRANCHI F, Rollini F, Rivas Rios J, Rivas A, et al
    Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study.
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.033983.
    PubMed     Text format     Abstract available


  323. RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
    PubMed     Text format     Abstract available


  324. SMILOWITZ NR, Beckman JA, Sherman SE, Berger JS, et al
    Hospital Readmission After Perioperative Acute Myocardial Infarction Associated With Noncardiac Surgery.
    Circulation. 2018 Mar 10. pii: CIRCULATIONAHA.117.032086.
    PubMed     Text format     Abstract available


  325. BLEWER AL, Abella BS
    Unmeasured Interface in Emergency Cardiovascular Care: How Do Dispatch-Assisted Telephone Cardiopulmonary Resuscitation and Bystander Training Interact?
    Circulation. 2018;137:996-998.
    PubMed     Text format    


    February 2018
  326. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
    Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of C
    Circulation. 2018;137:989-991.
    PubMed     Text format    


  327. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovas
    Circulation. 2018;137:988.
    PubMed     Text format    


  328. TAEGTMEYER H, Karlstaedt A
    Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Card
    Circulation. 2018;137:986-987.
    PubMed     Text format    


  329. KOH KK
    Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in
    Circulation. 2018;137:984-985.
    PubMed     Text format    


  330. TAMPAKI EC, Tampakis A, Pantos C
    Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular O
    Circulation. 2018;137:982-983.
    PubMed     Text format    


  331. KUEHN BM
    Gene-Editing Technology Accelerates Cardiovascular Research: Clinical Applications Being Explored.
    Circulation. 2018;137:973-974.
    PubMed     Text format    


  332. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    Circulation. 2018;137:961-972.
    PubMed     Text format     Abstract available


  333. ANDERSON CAM
    Dietary Patterns to Reduce Weight and Optimize Cardiovascular Health: Persuasive Evidence for Promoting Multiple, Healthful Approaches.
    Circulation. 2018 Feb 26. pii: CIRCULATIONAHA.117.031429.
    PubMed     Text format     Abstract available


  334. SOFI F, Dinu M, Pagliai G, Cesari F, et al
    Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet).
    Circulation. 2018 Feb 26. pii: CIRCULATIONAHA.117.030088.
    PubMed     Text format     Abstract available


  335. HAYES SN, Kim ESH, Saw J, Adlam D, et al
    Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Feb 22. pii: CIR.0000000000000564.
    PubMed     Text format     Abstract available


  336. PAYNTER NP, Balasubramanian R, Giulianini F, Wang DD, et al
    Metabolic Predictors of Incident Coronary Heart Disease in Women.
    Circulation. 2018;137:841-853.
    PubMed     Text format     Abstract available


  337. VACCARINO V, Sullivan S, Hammadah M, Wilmot K, et al
    Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms.
    Circulation. 2018;137:794-805.
    PubMed     Text format     Abstract available


  338. LICHTMAN JH, Leifheit EC, Safdar B, Bao H, et al
    Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients).
    Circulation. 2018;137:781-790.
    PubMed     Text format     Abstract available


  339. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Text format     Abstract available


  340. LERCHENMULLER C, Lerchenmueller MJ, Sorenson O
    Long-Term Analysis of Sex Differences in Prestigious Authorships in Cardiovascular Research Supported by the National Institutes of Health.
    Circulation. 2018;137:880-882.
    PubMed     Text format    


  341. ZOET GA, Benschop L, Boersma E, Budde RPJ, et al
    Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia.
    Circulation. 2018;137:877-879.
    PubMed     Text format    


  342. WEI J, Bakir M, Darounian N, Li Q, et al
    Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
    Circulation. 2018;137:874-876.
    PubMed     Text format    


  343. MINISSIAN MB, Kilpatrick S, Eastwood JA, Robbins WA, et al
    Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease.
    Circulation. 2018;137:865-871.
    PubMed     Text format     Abstract available


  344. O'NEIL A, Scovelle AJ, Milner AJ, Kavanagh A, et al
    Gender/Sex as a Social Determinant of Cardiovascular Risk.
    Circulation. 2018;137:854-864.
    PubMed     Text format     Abstract available


  345. PINA IL, Zheng Q, She L, Szwed H, et al
    Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Circulation. 2018;137:771-780.
    PubMed     Text format     Abstract available


  346. GRAVES CR, Davis SF
    Cardiovascular Complications in Pregnancy: It Is Time for Action.
    Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.031592.
    PubMed     Text format     Abstract available


  347. SAVONITTO S, Ferri LA, Piatti L, Grosseto D, et al
    A Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization.
    Circulation. 2018 Feb 19. pii: CIRCULATIONAHA.117.032180.
    PubMed     Text format     Abstract available


  348. TRIANT VA, Perez J, Regan S, Massaro JM, et al
    Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.028975.
    PubMed     Text format     Abstract available



  349. Correction to: Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Pr
    Circulation. 2018;137:e29.
    PubMed     Text format    


  350. HADLEY MB, Baumgartner J, Vedanthan R
    Developing a Clinical Approach to Air Pollution and Cardiovascular Health.
    Circulation. 2018;137:725-742.
    PubMed     Text format     Abstract available


  351. KHERA A, Greenland P
    Coronary Artery Calcium: If Measuring Once Is Good, Is Twice Better?
    Circulation. 2018;137:680-683.
    PubMed     Text format    


  352. ASRRESS KN, Williams R, Lockie T, Khawaja MZ, et al
    Response by Asrress et al to Letter Regarding Article, "Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise".
    Circulation. 2018;137:755-756.
    PubMed     Text format    


  353. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise".
    Circulation. 2018;137:754.
    PubMed     Text format    


  354. COLLET C, Katagiri Y, Miyazaki Y, Asano T, et al
    Impact of Coronary Remodeling on Fractional Flow Reserve.
    Circulation. 2018;137:747-749.
    PubMed     Text format    


  355. KONG P, Shinde AV, Su Y, Russo I, et al
    Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium.
    Circulation. 2018;137:707-724.
    PubMed     Text format     Abstract available


  356. GOTTESMAN RF
    Survivor's Remorse: Is There an Increased Risk of Dementia After Surviving a Myocardial Infarction?
    Circulation. 2018;137:578-580.
    PubMed     Text format    


  357. CAO D, Schiattarella GG, Villalobos E, Jiang N, et al
    Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury.
    Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.031046.
    PubMed     Text format     Abstract available


  358. MEHTA LS, Watson KE, Barac A, Beckie TM, et al
    Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Feb 1. pii: CIR.0000000000000556.
    PubMed     Text format     Abstract available


    January 2018
  359. MERGHANI A, Maestrini V, Rosmini S, Cox AT, et al
    Response by Merghani et al to Letters Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:541-542.
    PubMed     Text format    


  360. SCHMERMUND A
    Letter by Schmermund Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:539-540.
    PubMed     Text format    


  361. HARRELL TE, Stoebner RA, Boswell GE
    Letter by Harrell et al Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:537-538.
    PubMed     Text format    


  362. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Circulation. 2018;137:536.
    PubMed     Text format    


  363. RENA G, Lang CC
    Repurposing Metformin for Cardiovascular Disease.
    Circulation. 2018;137:422-424.
    PubMed     Text format    


  364. DEFILIPPI C, Seliger S
    The Cardiac Troponin Renal Disease Diagnostic Conundrum: Past, Present, and Future.
    Circulation. 2018;137:452-454.
    PubMed     Text format    


  365. FARRE J, Wellens HJ
    Unique ECG During Sinus Rhythm in a Patient With a Postmyocardial Infarction-Sustained Ventricular Tachycardia.
    Circulation. 2018;137:527-530.
    PubMed     Text format    


  366. KUEHN BM
    Sham-Controlled Trial Questions Benefit of Stents for Stable Angina.
    Circulation. 2018;137:519-520.
    PubMed     Text format    


  367. ALI ZA, Gao R, Kimura T, Onuma Y, et al
    Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
    Circulation. 2018;137:464-479.
    PubMed     Text format     Abstract available


  368. SIMES J, Robledo KP, White HD, Espinoza D, et al
    D-dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events and Cancer in Stable Coronary Heart Disease Patients: The LIPID Study.
    Circulation. 2018 Jan 24. pii: CIRCULATIONAHA.117.029901.
    PubMed     Text format     Abstract available


  369. HOFMANN R, James SK
    Routine Oxygen Supplementation in Acute Cardiovascular Disease: The End of a Paradigm?
    Circulation. 2018;137:320-322.
    PubMed     Text format    


  370. SOTANANUSAK T, Meemook K
    Asymptomatic ST-Segment-Elevation ECG in Patient With Kidney Failure.
    Circulation. 2018;137:402-404.
    PubMed     Text format    


  371. RADFORD NB, DeFina LF, Leonard D, Barlow CE, et al
    Cardiorespiratory Fitness, Coronary Artery Calcium and Cardiovascular Disease Events in a Cohort of Generally Healthy, Middle Aged Men: Results from the Cooper Center Longitudinal Study.
    Circulation. 2018 Jan 17. pii: CIRCULATIONAHA.117.032708.
    PubMed     Text format     Abstract available


  372. BARTOS JA, Doonan AL, Yannopoulos D
    Identifying Candidates for Advanced Hemodynamic Support After Cardiac Arrest.
    Circulation. 2018;137:283-285.
    PubMed     Text format    


  373. WANG Y, Tan X, Gao H, Yuan H, et al
    Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection.
    Circulation. 2018;137:259-269.
    PubMed     Text format     Abstract available


  374. BASCOM KE, Dziodzio J, Vasaiwala S, Mooney M, et al
    Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest.
    Circulation. 2018;137:273-282.
    PubMed     Text format     Abstract available


  375. EMDIN CA, Khera AV, Klarin D, Natarajan P, et al
    Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
    Circulation. 2018;137:222-232.
    PubMed     Text format     Abstract available


  376. IANIRO G, Cammarota G, Gasbarrini A
    Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium".
    Circulation. 2018;137:213-214.
    PubMed     Text format    


  377. JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
    Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
    Circulation. 2018;137:206-209.
    PubMed     Text format    


  378. BEDDHU S, Chertow GM, Cheung AK, Cushman WC, et al
    Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Circulation. 2018;137:134-143.
    PubMed     Text format     Abstract available



  379. Correction to: 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular
    Circulation. 2018;137:e14.
    PubMed     Text format    


    December 2017
  380. GIUGLIANO RP, Cannon CP, Blazing MA, Nicolau JC, et al
    Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT.
    Circulation. 2017 Dec 20. pii: CIRCULATIONAHA.117.030950.
    PubMed     Text format     Abstract available



  381. Correction to: Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2017;136:e469.
    PubMed     Text format    


  382. BENSON MD, Yang Q, Ngo D, Zhu Y, et al
    The Genetic Architecture of the Cardiovascular Risk Proteome.
    Circulation. 2017 Dec 19. pii: CIRCULATIONAHA.117.029536.
    PubMed     Text format     Abstract available



  383. Correction to: 2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2017;136:e468.
    PubMed     Text format    


  384. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
    Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
    PubMed     Text format     Abstract available


  385. GOLDSTONE AB, Chiu P, Baiocchi M, Wang H, et al
    Second Arterial versus Venous Conduits for Multi-Vessel Coronary Artery Bypass Surgery in California.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.030959.
    PubMed     Text format     Abstract available


  386. GAO L, Gregorich ZR, Zhu W, Mattapally S, et al
    Large Cardiac-Muscle Patches Engineered from Human Induced-Pluripotent Stem-Cell-Derived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine.
    Circulation. 2017 Dec 12. pii: CIRCULATIONAHA.117.030785.
    PubMed     Text format     Abstract available


  387. AHN JM, Park SJ
    Response by Ahn and Park to Letter Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)"
    Circulation. 2017;136:2393-2394.
    PubMed     Text format    


  388. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)".
    Circulation. 2017;136:2392.
    PubMed     Text format    


  389. HAN YL, Rutherford JD
    Recent Evolution of the Treatment of Coronary Artery Disease in China: A Conversation With Ya-Ling Han, MD, PhD.
    Circulation. 2017;136:2298-2302.
    PubMed     Text format    


  390. FRANKENREITER S, Bednarczyk P, Kniess A, Bork NI, et al
    cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Circulation. 2017;136:2337-2355.
    PubMed     Text format     Abstract available


  391. ZHANG L, Wei TT, Li Y, Li J, et al
    Functional Metabolomics Characterizes a Key Role for N-Acetyl-Neuraminic Acid in Coronary Artery Diseases.
    Circulation. 2017 Dec 6. pii: CIRCULATIONAHA.117.031139.
    PubMed     Text format     Abstract available


    November 2017
  392. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)".
    Circulation. 2017;136:2202-2203.
    PubMed     Text format    


  393. YAN W, Guo Y, Tao L, Lau WB, et al
    C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.
    Circulation. 2017;136:2162-2177.
    PubMed     Text format     Abstract available


  394. CHANG AM, Litt HI, Snyder BS, Gatsonis C, et al
    Impact of Coronary Computed Tomography Angiography Findings on Initiation of Cardioprotective Medications.
    Circulation. 2017;136:2195-2197.
    PubMed     Text format    


  395. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
    Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
    Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
    PubMed     Text format     Abstract available


  396. HORCKMANS M, Bianchini M, Santovito D, Megens RTA, et al
    Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.028833.
    PubMed     Text format     Abstract available


  397. JENSEN MK, Aroner SA, Mukamal KJ, Furtado JD, et al
    HDL Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
    Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.031276.
    PubMed     Text format     Abstract available


  398. CICCARELLI G, Barbato E, Toth GG, Gahl B, et al
    Angiography versus Hemodynamics to Predict the Natural History of Coronary Stenoses: A FAME 2-Substudy.
    Circulation. 2017 Nov 21. pii: CIRCULATIONAHA.117.028782.
    PubMed     Text format     Abstract available


  399. CHAPMAN AR, Shah ASV, Lee KK, Anand A, et al
    Long Term Outcomes in Patients with Type 2 Myocardial Infarction and Myocardial Injury.
    Circulation. 2017 Nov 17. pii: CIRCULATIONAHA.117.031806.
    PubMed     Text format     Abstract available


  400. LEHMANN N, Erbel RA, Mahabadi AA, Rauwolf M, et al
    Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the Heinz Nixdorf Recall (HNR) Study.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.116.027034.
    PubMed     Text format     Abstract available


  401. JOLLIS JG, Al-Khalidi HR, Roettig ML, Berger PB, et al
    Impact of Regionalization of ST Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services Transported Patients Presenting to Hospitals with Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.
    Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.032446.
    PubMed     Text format     Abstract available


  402. THAN MP, Pickering JW, Dryden JM, Lord SJ, et al
    ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway.
    Circulation. 2017 Nov 14. pii: CIRCULATIONAHA.117.031984.
    PubMed     Text format     Abstract available


  403. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1984.
    PubMed     Text format    


  404. NATALE F, Di Maio M, Calabro P
    Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1982-1983.
    PubMed     Text format    


  405. KHERA R, Hong JC, Saxena A, Arrieta A, et al
    Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
    PubMed     Text format     Abstract available


  406. UDELL JA, Yuan Z, Rush T, Sicignano NM, et al
    Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227.
    PubMed     Text format     Abstract available


  407. BONACA MP, Nault P, Giugliano RP, Keech AC, et al
    Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032235.
    PubMed     Text format     Abstract available


  408. MAHAFFEY KW, Neal B, Perkovic V, de Zeeuw D, et al
    Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032038.
    PubMed     Text format     Abstract available


  409. VERMA S, Mazer CD, Al-Omran M, Inzucchi SE, et al
    Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032031.
    PubMed     Text format     Abstract available


  410. BURSTEIN B, Altobelli KK, Williams K, Cannon CP, et al
    Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Circulation. 2017;136:1860-1862.
    PubMed     Text format    


  411. DRAGER LF, McEvoy RD, Barbe F, Lorenzi-Filho G, et al
    Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.
    Circulation. 2017;136:1840-1850.
    PubMed     Text format     Abstract available


  412. LEE JM, Hwang D, Park J, Zhang J, et al
    Exploring Coronary Circulatory Response to Stenosis and Its Association With Invasive Physiologic Indexes Using Absolute Myocardial Blood Flow and Coronary Pressure.
    Circulation. 2017;136:1798-1808.
    PubMed     Text format     Abstract available


  413. OLASVEENGEN TM, de Caen AR, Mancini ME, Maconochie IK, et al
    2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000541.
    PubMed     Text format     Abstract available


  414. ATKINS DL, de Caen AR, Berger S, Samson RA, et al
    2017 American Heart Association Focused Update on Pediatric Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000540.
    PubMed     Text format     Abstract available


  415. KLEINMAN ME, Goldberger ZD, Rea T, Swor RA, et al
    2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality: An Update to the American Heart Association Guidelines for Cardio pulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2017 Nov 6. pii: CIR.0000000000000539.
    PubMed     Text format     Abstract available


  416. TWERENBOLD R, Badertscher P, Boeddinghaus J, Nestelberger T, et al
    0/1-Hour Triage Algorithm for Myocardial Infarction in Patients with Renal Dysfunction.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028901.
    PubMed     Text format     Abstract available


  417. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Text format     Abstract available


  418. FEARON WF, Nishi T, De Bruyne B, Boothroyd DB, et al
    Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Mul
    Circulation. 2017 Nov 2. pii: CIRCULATIONAHA.117.031907.
    PubMed     Text format     Abstract available


    October 2017
  419. GAUDINO M, Antoniades C, Benedetto U, Deb S, et al
    Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
    Circulation. 2017;136:1749-1764.
    PubMed     Text format     Abstract available


  420. HENG EL, Gatzoulis MA, Uebing A, Sethia B, et al
    Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study.
    Circulation. 2017;136:1703-1713.
    PubMed     Text format     Abstract available


  421. IRIBARNE A, Schmoker JD, Malenka DJ, Leavitt BJ, et al
    Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.
    Circulation. 2017;136:1676-1685.
    PubMed     Text format     Abstract available


  422. RUEL M, Gardner TJ
    Introduction to the 2017 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2017;136:1675.
    PubMed     Text format    


  423. CAVALLARI I, Morrow DA, Creager MA, Olin J, et al
    Frequency, Predictors and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients with Symptomatic Atherosclerosis.
    Circulation. 2017 Oct 30. pii: CIRCULATIONAHA.117.031062.
    PubMed     Text format     Abstract available


  424. KRITTANAWONG C
    Future Physicians in the Era of Precision Cardiovascular Medicine.
    Circulation. 2017;136:1572-1574.
    PubMed     Text format    


  425. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    PubMed     Text format     Abstract available


  426. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    PubMed     Text format     Abstract available


  427. MCEVOY JW, Ibrahim K, Kickler TS, Clarke WA, et al
    Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial.
    Circulation. 2017 Oct 18. pii: CIRCULATIONAHA.117.031678.
    PubMed     Text format     Abstract available


  428. VAN DIEPEN S, Katz JN, Albert NM, Henry TD, et al
    Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e232-e268.
    PubMed     Text format     Abstract available


  429. BORTOLOTTI F, Ruozi G, Falcione A, Doimo S, et al
    In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells.
    Circulation. 2017;136:1509-1524.
    PubMed     Text format     Abstract available


  430. WOLSK E, Claggett B, Diaz R, Dickstein K, et al
    Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Circulation. 2017;136:1560-1562.
    PubMed     Text format    


  431. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
    Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
    PubMed     Text format     Abstract available


  432. MCCARROLL CS, He W, Foote K, Bradley A, et al
    Runx1 Deficiency Protects Against Adverse Cardiac Remodeling Following Myocardial Infarction.
    Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.117.028911.
    PubMed     Text format     Abstract available


  433. SUNA G, Wojakowski W, Lynch M, Barallobre-Barreiro J, et al
    Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.
    Circulation. 2017 Oct 13. pii: CIRCULATIONAHA.116.023381.
    PubMed     Text format     Abstract available


  434. SUNDBOLL J, Hovath-Puho E, Adelborg K, Schmidt M, et al
    Higher Risk of Vascular Dementia in Myocardial Infarction Survivors.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.029127.
    PubMed     Text format     Abstract available


  435. HASEEB S, Alexander B, Baranchuk A
    Wine and Cardiovascular Health: A Comprehensive Review.
    Circulation. 2017;136:1434-1448.
    PubMed     Text format     Abstract available


  436. LACRAZ GPA, Junker JP, Gladka MM, Molenaar B, et al
    Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury.
    Circulation. 2017;136:1396-1409.
    PubMed     Text format     Abstract available


  437. MILLER-HODGES EV, Anand A, Shah ASV, Chapman AR, et al
    High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients with Renal Impairment Presenting with Suspected Acute Coronary Syndrome.
    Circulation. 2017 Oct 4. pii: CIRCULATIONAHA.117.030320.
    PubMed     Text format     Abstract available


  438. SMOLDEREN KGE, Gosch KG, Buchanan DM, Spertus JA, et al
    Response by Smolderen et al to Letter Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial
    Circulation. 2017;136:1355-1356.
    PubMed     Text format    


  439. MA LL, Kong FJ, Ge JB
    Letter by Ma et al Regarding Article, "Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients
    Circulation. 2017;136:1353-1354.
    PubMed     Text format    


  440. HEAD SJ, Milojevic M, Taggart DP, Puskas JD, et al
    Current Practice of State-of-the-Art Surgical Coronary Revascularization.
    Circulation. 2017;136:1331-1345.
    PubMed     Text format     Abstract available


  441. ARAI AE
    Time-Varying Edema Requires Cautious Interpretation of Myocardium at Risk and Infarct Size by All Imaging Methods.
    Circulation. 2017;136:1301-1303.
    PubMed     Text format    


  442. WONG KL, Taner T, Smith BH, Kushwaha SS, et al
    Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation.
    Circulation. 2017;136:1350-1352.
    PubMed     Text format    


    September 2017
  443. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Text format     Abstract available


  444. BERRY C, McClure JD, Oldroyd KG
    Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.030430.
    PubMed     Text format     Abstract available


  445. GOYAL A, Gluckman TJ, Tcheng JE
    What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction.
    Circulation. 2017;136:1180-1182.
    PubMed     Text format    


  446. WILSON PWF, Gagnon D
    Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual Care.
    Circulation. 2017;136:1204-1206.
    PubMed     Text format    


  447. SUNDSTROM J, Hedberg J, Thuresson M, Aarskog P, et al
    Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study.
    Circulation. 2017;136:1183-1192.
    PubMed     Text format     Abstract available


  448. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
    Direct Comparison of Cardiac Myosin-Binding Protein C with Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028084.
    PubMed     Text format     Abstract available


  449. REBOLL MR, Korf-Klingebiel M, Klede S, Polten F, et al
    Endoplasmic Reticulum Membrane Protein Complex Subunit 10 (EMC10) is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
    Circulation. 2017 Sep 20. pii: CIRCULATIONAHA.117.029980.
    PubMed     Text format     Abstract available


  450. CREA F, Libby P
    Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.
    Circulation. 2017;136:1155-1166.
    PubMed     Text format     Abstract available


  451. QUAIFE-RYAN GA, Sim CB, Ziemann M, Kaspi A, et al
    Multicellular Transcriptional Analysis of Mammalian Heart Regeneration.
    Circulation. 2017;136:1123-1139.
    PubMed     Text format     Abstract available


  452. NALLAMOTHU BK, Hill JA
    Preprints and Cardiovascular Science: Prescient or Premature?
    Circulation. 2017 Sep 14. pii: CIRCULATIONAHA.117.031238.
    PubMed     Text format     Abstract available


  453. WANNER C, Lachin JM, Inzucchi SE, Fitchett D, et al
    Empagliflozin and Clinical Outcomes in Patients with Type 2 Diabetes, Established Cardiovascular Disease and Chronic Kidney Disease.
    Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028268.
    PubMed     Text format     Abstract available


  454. LINDAHL B, Baron T, Erlinge D, Hadziosmanovic N, et al
    Response by Lindahl et al to Letter Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
    Circulation. 2017;136:1082-1083.
    PubMed     Text format    


  455. CILIBERTI G, Capucci A
    Letter by Ciliberti and Capucci Regarding Article, "Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease".
    Circulation. 2017;136:1080-1081.
    PubMed     Text format    


  456. DEHARO P, Ducrocq G, Bode C, Cohen M, et al
    Timing of Angiography and Outcomes in High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction Managed Invasively: Insights from the TAO Trial.
    Circulation. 2017 Sep 11. pii: CIRCULATIONAHA.117.029779.
    PubMed     Text format     Abstract available


    August 2017
  457. WANG WE, Li L, Xia X, Fu W, et al
    Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.
    Circulation. 2017;136:834-848.
    PubMed     Text format     Abstract available


  458. ARMSTRONG PW, Welsh RC
    Recalibrating Reperfusion Waypoints.
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030869.
    PubMed     Text format     Abstract available


    May 2017
  459. JOLLY SS, James S, Dzavik V, Cairns JA, et al
    Response by Jolly et al to Letters Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1103-e1104.
    PubMed     Text format    


  460. SHAH R
    Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1101-e1102.
    PubMed     Text format    


  461. JURADO-ROMAN A, Sanchez-Perez I, Lozano-Ruiz-Poveda F
    Letter by Jurado-Roman et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1099-e1100.
    PubMed     Text format    


  462. KARAMASIS GV, Davies JR, Clesham GJ
    Letter by Karamasis et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1097-e1098.
    PubMed     Text format    


  463. DAVIDSON KW
    Waiting for Godot: Engaging in Discussions About Depression Care in Patients With Acute Myocardial Infarction While Waiting for a Definitive Trial That Never Appears.
    Circulation. 2017;135:1690-1692.
    PubMed     Text format    


  464. SMOLDEREN KG, Spertus JA, Gosch K, Dreyer RP, et al
    Depression Treatment and Health Status Outcomes in Young Patients With Acute Myocardial Infarction: Insights From the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients).
    Circulation. 2017;135:1762-1764.
    PubMed     Text format    


    March 2017
  465. CAPOULADE R, Bowdish M, Kron IL, Smith P, et al
    Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e785-e786.
    PubMed     Text format    


  466. POCAR M
    Letter by Pocar Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e783-e784.
    PubMed     Text format    


    January 2017
  467. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    PubMed     Text format    


  468. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: